• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国2型糖尿病男性勃起功能障碍的患病率

Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus.

作者信息

Cho N H, Ahn C W, Park J Y, Ahn T Y, Lee H W, Park T S, Kim I J, Pomerantz K, Park C, Kimm K C, Choi D S

机构信息

Department of Internal Medicine, Yonsei University, Seoul, Korea.

出版信息

Diabet Med. 2006 Feb;23(2):198-203. doi: 10.1111/j.1464-5491.2005.01789.x.

DOI:10.1111/j.1464-5491.2005.01789.x
PMID:16433719
Abstract

AIMS

We investigated the prevalence and risk factors for developing erectile dysfunction (ED) in 1312 Korean men with diabetes in a multicentre study.

METHODS

We used the modified International Index for Erectile Function-5 criteria to identify mild, moderate and complete ED. A standardized face-to-face questionnaire was used by trained interviewers, and validated against telephone interviews. We recorded the duration of diabetes, level of glycaemic control, vital signs, complications, exercise and alcohol and smoking habits, and diabetes treatments used. Results The mean age and median duration of diabetes were 53.8 +/- 6.65 and 6 years (range 1-43), respectively. The mean HbA(1c) and fasting glucose levels were 7.9 +/- 1.65% and 8.6 +/- 2.82 mmol/l, respectively. The overall prevalences of mild, moderate, complete ED and all ED (mild-to-complete) were 20.1, 19.5, 25.8 and 65.4%, respectively. ED was more common with age, reaching 79.3% in men aged > 60 years. Subjects aged > 60 years and with a duration of diabetes > 10 years were at greatest risk for all ED (OR = 10.4, 95% CI 5.8-18.5, P < 0.001) and complete ED (OR = 13.2, 95% CI 7.3-23.9, P < 0.001) when compared with the reference group (age 40-50 years with duration < 6 years). Age, duration of diabetes, HbA(1c), insulin use, neuropathy and macrovascular complications were positively associated with ED, but alcohol consumption and exercise habits were negatively associated.

CONCLUSIONS

The prevalence of complete ED was approximately six times higher than in the general population.

摘要

目的

在一项多中心研究中,我们调查了1312名韩国糖尿病男性勃起功能障碍(ED)的患病率及其危险因素。

方法

我们采用改良的国际勃起功能指数-5标准来确定轻度、中度和重度ED。由经过培训的访谈者使用标准化的面对面问卷,并通过电话访谈进行验证。我们记录了糖尿病病程、血糖控制水平、生命体征、并发症、运动及饮酒和吸烟习惯,以及所使用的糖尿病治疗方法。结果糖尿病患者的平均年龄和病程中位数分别为53.8±6.65岁和6年(范围1 - 43年)。平均糖化血红蛋白(HbA1c)水平和空腹血糖水平分别为7.9±1.65%和8.6±2.82 mmol/L。轻度、中度、重度ED及所有ED(轻度至重度)的总体患病率分别为20.1%、19.5%、25.8%和65.4%。ED随年龄增长更为常见,60岁以上男性中ED患病率达79.3%。与参照组(年龄40 - 50岁,病程<6年)相比,60岁以上且糖尿病病程>10年的受试者发生所有ED(比值比[OR]=10.4,95%置信区间[CI] 5.8 - 18.5,P<0.001)和重度ED(OR = 13.2,95% CI 7.3 - 23.9,P<0.001)的风险最高。年龄、糖尿病病程、HbA1c、胰岛素使用、神经病变和大血管并发症与ED呈正相关,而饮酒和运动习惯与ED呈负相关。

结论

重度ED的患病率约比普通人群高六倍。

相似文献

1
Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus.韩国2型糖尿病男性勃起功能障碍的患病率
Diabet Med. 2006 Feb;23(2):198-203. doi: 10.1111/j.1464-5491.2005.01789.x.
2
Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes.2型糖尿病男性患者血糖控制与勃起功能障碍风险的关联
J Sex Med. 2009 Jun;6(6):1719-1728. doi: 10.1111/j.1743-6109.2009.01219.x. Epub 2009 Mar 17.
3
Frequency and Risk Factors of Erectile Dysfunction among Bangladeshi Adult Men with Type 2 Diabetes Mellitus.孟加拉国成年2型糖尿病男性勃起功能障碍的发生率及危险因素
Mymensingh Med J. 2020 Jan;29(1):66-72.
4
Alcohol consumption and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: Baseline data from the Dogo Study.日本2型糖尿病患者的饮酒情况与勃起功能障碍患病率:来自道后研究的基线数据。
Alcohol. 2016 Sep;55:17-22. doi: 10.1016/j.alcohol.2016.07.006. Epub 2016 Aug 25.
5
Prevalence and risk factors for erectile dysfunction in Japanese diabetics.日本糖尿病患者勃起功能障碍的患病率及危险因素
Diabetes Res Clin Pract. 2005 Oct;70(1):81-9. doi: 10.1016/j.diabres.2005.02.018. Epub 2005 Apr 15.
6
Prevalence of, and risk factors for erectile dysfunction in male type 2 diabetic outpatient attendees in Enugu, South East Nigeria.尼日利亚东南部埃努古男性2型糖尿病门诊患者勃起功能障碍的患病率及危险因素
Ann Afr Med. 2018 Oct-Dec;17(4):215-220. doi: 10.4103/aam.aam_3_18.
7
Self-reported sitting time and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study.日本2型糖尿病患者的自我报告久坐时间与勃起功能障碍患病率:道后研究
J Diabetes Complications. 2017 Jan;31(1):53-57. doi: 10.1016/j.jdiacomp.2016.10.011. Epub 2016 Oct 18.
8
Frequency and Predictors of Erectile Dysfunction in Bangladeshi Men with Type 2 Diabetes Mellitus: Experience from a Tertiary Center.孟加拉国2型糖尿病男性勃起功能障碍的发生率及预测因素:来自三级中心的经验
Mymensingh Med J. 2019 Jan;28(1):137-143.
9
Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan.苏丹东部 2 型糖尿病男性勃起功能障碍的患病率及相关因素。
BMC Endocr Disord. 2022 May 28;22(1):141. doi: 10.1186/s12902-022-01060-0.
10
Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.糖尿病严重程度、代谢综合征与勃起功能障碍风险。
J Sex Med. 2013 Dec;10(12):3102-9. doi: 10.1111/jsm.12318. Epub 2013 Sep 9.

引用本文的文献

1
MicroRNAs as diagnostic biomarkers in diabetes male infertility: a systematic review.微小RNA作为糖尿病男性不育症诊断生物标志物的系统评价
Mol Biol Rep. 2024 Dec 30;52(1):90. doi: 10.1007/s11033-024-10197-1.
2
The global burden of erectile dysfunction and its associated risk factors in diabetic patients: an umbrella reviews.全球糖尿病患者勃起功能障碍及其相关危险因素的负担:一项伞式综述。
BMC Public Health. 2024 Oct 14;24(1):2816. doi: 10.1186/s12889-024-20300-7.
3
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trial.
糖尿病性勃起功能障碍男性的干细胞治疗:两次海绵体内自体骨髓间充质干细胞注射安全性和有效性的24个月随访,一项开放标签的2期临床试验
Basic Clin Androl. 2024 Jul 5;34(1):13. doi: 10.1186/s12610-024-00229-y.
4
The Effects of a Red-Light Controllable Nitric Oxide Donor, NORD-1, on Erectile Dysfunction in Rats with Streptozotocin Induced Diabetes Mellitus.红光可控一氧化氮供体NORD-1对链脲佐菌素诱导的糖尿病大鼠勃起功能障碍的影响
World J Mens Health. 2025 Jan;43(1):197-204. doi: 10.5534/wjmh.230362. Epub 2024 May 20.
5
Treatment Outcomes of Diabetic Patients With Erectile Dysfunction Prescribed High-Dose Tadalafil.接受高剂量他达拉非治疗的糖尿病性勃起功能障碍患者的治疗结果
Cureus. 2023 Feb 9;15(2):e34812. doi: 10.7759/cureus.34812. eCollection 2023 Feb.
6
INFLUENCE OF THE DURATION OF DIABETES AND VIBRATION PERCEPTION THRESHOLD ON THE SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.2型糖尿病患者糖尿病病程及振动觉阈值对勃起功能障碍严重程度的影响
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):174-180. doi: 10.4183/aeb.2022.174.
7
Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual health.亚洲糖尿病管理中的差距:需要提高对男性性健康的认识和采取相应策略。
J Diabetes Investig. 2022 Dec;13(12):1945-1957. doi: 10.1111/jdi.13903. Epub 2022 Sep 24.
8
Analysis of the Factors Associated With ED in Type 2 Diabetics at the University Hospital of Libreville.利伯维尔大学医院2型糖尿病患者勃起功能障碍相关因素分析
Sex Med. 2022 Dec;10(6):100564. doi: 10.1016/j.esxm.2022.100564. Epub 2022 Sep 17.
9
Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan.苏丹东部 2 型糖尿病男性勃起功能障碍的患病率及相关因素。
BMC Endocr Disord. 2022 May 28;22(1):141. doi: 10.1186/s12902-022-01060-0.
10
Stem cell therapy and diabetic erectile dysfunction: A critical review.干细胞疗法与糖尿病性勃起功能障碍:一项批判性综述。
World J Stem Cells. 2021 Oct 26;13(10):1549-1563. doi: 10.4252/wjsc.v13.i10.1549.